Table 1.
ICM (n = 18) | |
---|---|
Age (years) |
54.53 ± 2.67 |
Gender male (%) |
93 % |
Prior hypertension (%) |
46 |
Diabetes mellitus (%) |
27 |
Obesity (%) |
20 |
Total cholesterol (nmol/L) |
3.90 ± 0.28 |
Perfusion abnormalities* (%) |
67 % |
Ejection fraction (%) |
25.86 ± 1.80 |
Intraventricular septum in diastole (mm) |
11.08 ± 0.47 |
Left ventricular posterior wall in diastole (mm) |
9.67 ± 0.62 |
Left ventricular end-diastolic diameter (mm) |
67.00 ± 2.45 |
Left ventricular end-systolic diameter (mm) |
58.50 ± 3.94 |
Diuretics |
90 |
Angiotensin-converting enzymes inhibitors |
87 |
β-blockers |
50 |
Aldosterone antagonist |
70 |
Digoxin |
49 |
Statins | 80 |
ICM, ischemic cardiomyopahhy; *the patients with perfusion abnormalities were considered those subjected to coronary interventions (i.e. by-pass, angioplasty, stents and others).